169 related articles for article (PubMed ID: 24406282)
1. N Latex FLC serum free light-chain assays in patients with renal impairment.
Jacobs JF; Hoedemakers RM; Teunissen E; Te Velthuis H
Clin Chem Lab Med; 2014 Jun; 52(6):853-9. PubMed ID: 24406282
[TBL] [Abstract][Full Text] [Related]
2. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
[TBL] [Abstract][Full Text] [Related]
3. The association of serum-free light-chain levels with markers of renal function.
Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
[TBL] [Abstract][Full Text] [Related]
4. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Freelite and N-Latex serum free light chain assays: a critical review.
Daves M; Piccin A; Roccaforte V; Lippi G
Biochem Med (Zagreb); 2021 Oct; 31(3):030701. PubMed ID: 34393594
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment.
Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K
Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061
[TBL] [Abstract][Full Text] [Related]
12. Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency.
Xu L; Zhao B; Sun Y; Wang S; Chen X; Mao Y
Biomed Res Int; 2022; 2022():5536199. PubMed ID: 35392256
[TBL] [Abstract][Full Text] [Related]
13. Method comparison of four clinically available assays for serum free light chain analysis.
Fleming CKA; Swarttouw T; de Kat Angelino CM; Jacobs JFM; Russcher H
Clin Chem Lab Med; 2019 Dec; 58(1):85-94. PubMed ID: 31730518
[TBL] [Abstract][Full Text] [Related]
14. Response to Jacobs: N Latex FLC serum free light-chain assays in patients with renal impairment.
Berlanga O; Carr-Smith H; Harding S
Clin Chem Lab Med; 2014 Nov; 52(11):e243-5. PubMed ID: 24926627
[No Abstract] [Full Text] [Related]
15. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
Lutteri L; Aldenhoff MC; Cavalier E
Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
[TBL] [Abstract][Full Text] [Related]
17. Serum free light chain reference values: a critical approach.
Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Free Light Chain Assays: Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis.
Mahmood S; Wassef NL; Salter SJ; Sachchithanantham S; Lane T; Foard D; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Am J Clin Pathol; 2016 Jul; 146(1):78-85. PubMed ID: 27353767
[TBL] [Abstract][Full Text] [Related]
20. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
